Immune Responses and Long-Term Disease Recurrence Status After Telomerase-Based Dendritic Cell Immunotherapy in Patients With Acute Myeloid Leukemia
Cancer - United States
doi 10.1002/cncr.30696
Full Text
Open PDFAbstract
Available in full text
Date
April 14, 2017
Authors
Publisher
Wiley